Fibrate drugs (including bezafibrate, clofibrate, fenofibrate, gemfibrozil, ronifibrate, etc.)are a class of classical PPARα agonists used to treat hyperlipidaemia and increase high-density lipoprotein cholesterol (HDL-c) in clinical settings. The gene discussed is PPARA; the disease is hyperlipidemia.